Susanne H.c. Baumeister, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 8 | 2024 | 1503 | 1.140 |
Why?
|
| T-Lymphocytes | 8 | 2023 | 10263 | 0.850 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 4 | 2020 | 94 | 0.610 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 384 | 0.550 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 3633 | 0.440 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 230 | 0.360 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2018 | 1403 | 0.310 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2007 | 633 | 0.230 |
Why?
|
| Ligands | 3 | 2020 | 3274 | 0.230 |
Why?
|
| Bystander Effect | 1 | 2024 | 89 | 0.220 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5753 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 996 | 0.190 |
Why?
|
| Graft vs Host Disease | 3 | 2023 | 3079 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2023 | 4747 | 0.190 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 338 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5193 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 4652 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 2215 | 0.160 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 273 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9244 | 0.160 |
Why?
|
| Lymphocyte Transfusion | 1 | 2020 | 236 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2023 | 2571 | 0.160 |
Why?
|
| Histocompatibility Testing | 1 | 2020 | 726 | 0.150 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 606 | 0.150 |
Why?
|
| Macaca mulatta | 4 | 2024 | 2341 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1895 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2747 | 0.130 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2008 | 543 | 0.120 |
Why?
|
| Simian immunodeficiency virus | 3 | 2008 | 812 | 0.110 |
Why?
|
| Lymphoma, T-Cell | 1 | 2016 | 308 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 2234 | 0.110 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2008 | 827 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2016 | 371 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2024 | 5502 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2008 | 1362 | 0.090 |
Why?
|
| Cancer Vaccines | 1 | 2016 | 1042 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 17089 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3079 | 0.070 |
Why?
|
| Amino Sugars | 1 | 2007 | 39 | 0.070 |
Why?
|
| Inflammation | 1 | 2007 | 10863 | 0.070 |
Why?
|
| Neutrophils | 1 | 2020 | 3782 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 22350 | 0.070 |
Why?
|
| Cytokines | 2 | 2018 | 7438 | 0.070 |
Why?
|
| Receptors, CCR5 | 1 | 2008 | 491 | 0.060 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 540 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 244 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2007 | 581 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 766812 | 0.060 |
Why?
|
| Virus Replication | 2 | 2008 | 2457 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3942 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2006 | 995 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2022 | 444 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 2228 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2023 | 9358 | 0.040 |
Why?
|
| Gene Products, gag | 2 | 2008 | 317 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 1802 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5890 | 0.030 |
Why?
|
| Perforin | 1 | 2016 | 167 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4349 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4410 | 0.030 |
Why?
|
| Child | 4 | 2023 | 80670 | 0.030 |
Why?
|
| Animals | 6 | 2024 | 168939 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2023 | 81657 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65286 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 2127 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 892 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 1352 | 0.030 |
Why?
|
| Young Adult | 3 | 2023 | 59939 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1228 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4787 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8507 | 0.020 |
Why?
|
| Gene Products, tat | 1 | 2008 | 111 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3738 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 171344 | 0.020 |
Why?
|
| Adolescent | 2 | 2023 | 88902 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 223267 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 223305 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10451 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 8045 | 0.010 |
Why?
|
| Male | 2 | 2018 | 364154 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 36459 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14473 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 42577 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16722 | 0.010 |
Why?
|
| Female | 1 | 2018 | 396532 | 0.010 |
Why?
|
| Intestines | 1 | 2008 | 1904 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22351 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 3213 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3468 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6066 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5204 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13411 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12826 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17609 | 0.010 |
Why?
|
| Mutation | 2 | 2008 | 30214 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13642 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81898 | 0.010 |
Why?
|